Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30005504HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS30026671HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS30026672HIVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS20000916HPVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS20046556HPVENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44012771HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44010815HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TVIS44036114HTLV-1ENSG00000143799.14protein_codingPARP1NoYes142P09874
TCGA Plot Options
Drug Information
GenePARP1
DrugBank IDDB11760
Drug NameTalazoparib
Target IDBE0001717
UniProt IDP09874
Regulation Typeinhibitor
PubMed IDs26652717
CitationsWang B, Chu D, Feng Y, Shen Y, Aoyagi-Scharber M, Post LE: Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-te trahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent. J Med Chem. 2016 Jan 14;59(1):335-57. doi: 10.1021/acs.jmedchem.5b01498. Epub 2015 Dec 23.
GroupsApproved; Investigational
Direct ClassificationPhenylquinolines
SMILESCN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL3137320